{"id":4140,"date":"2017-06-30T12:36:46","date_gmt":"2017-06-30T20:36:46","guid":{"rendered":"https:\/\/drugpolicy.ca\/blog\/2017\/06\/interet-grandissant-a-linternational-pour-lanalyse-de-substances-points-forts-de-hr17\/"},"modified":"2019-11-01T13:01:38","modified_gmt":"2019-11-01T21:01:38","slug":"interet-grandissant-a-linternational-pour-lanalyse-de-substances-points-forts-de-hr17","status":"publish","type":"post","link":"https:\/\/mail.canadiandrugpolicy.ca\/fr\/interet-grandissant-a-linternational-pour-lanalyse-de-substances-points-forts-de-hr17\/","title":{"rendered":"INT\u00c9R\u00caT GRANDISSANT \u00c0 L\u2019INTERNATIONAL POUR L\u2019ANALYSE DE SUBSTANCES : POINTS FORTS DE HR17"},"content":{"rendered":"<p><em>Avec une attention internationale grandissante sur les impacts et le grand potentiel des services d\u2019analyse de substances, un certain nombre d&#8217;\u00e9v\u00e8nements \u00e0 la conf\u00e9rence de HR17 ont pr\u00e9sent\u00e9 des r\u00e9sultats de recherche ainsi que l\u2019exp\u00e9rience sur le terrain de cette pratique novatrice de r\u00e9duction des m\u00e9faits.<\/em><\/p>\n<p>Pour la premi\u00e8re fois de son histoire, la\u00a0<a href=\"https:\/\/www.hri.global\/conference-2017\" target=\"_blank\" rel=\"noopener noreferrer\">25e Conf\u00e9rence internationale sur la r\u00e9duction des m\u00e9faits (HR17)<\/a>\u00a0tenue \u00e0 Montr\u00e9al, au Canada, a donn\u00e9 une place importante \u00e0 l\u2019analyse de substances dans leur programmation. L\u2019analyse de substances est une intervention de r\u00e9duction des m\u00e9faits qui fournit aux personnes qui consomment des drogues de synth\u00e8se des informations sur la puret\u00e9, la puissance et la composition de celles-ci. La hausse de l&#8217;int\u00e9r\u00eat international pour la mise en place de services de l\u2019analyse de substances a permis \u00e0 plusieurs personnes d\u2019assister \u00e0 un atelier parall\u00e8le, un panel et une conf\u00e9rence de presse. Ceux-ci ont abord\u00e9 les r\u00e9percussions de l&#8217;analyse de substances sur la sant\u00e9 et le bien-\u00eatre des personnes qui utilisent de la drogue dans divers milieux ainsi que les multiples comportements li\u00e9s \u00e0 l&#8217;usage de drogue. \u00c0 l&#8217;occasion d&#8217;une conf\u00e9rence sur la r\u00e9duction des m\u00e9faits dans le contexte d&#8217;une crise de surdose d&#8217;opio\u00efdes, l\u2019analyse de substances sous forme de bandes de tests de fentanyl \u00e9tait offerte sur place dans la salle m\u00e9dicale de la conf\u00e9rence.<\/p>\n<p>Le 14 mai 2017 avant l&#8217;ouverture officielle de HR17, les membres d&#8217;un Groupe de travail national canadien sur l\u2019analyse de substances ont organis\u00e9 un \u00ab\u00a0<a href=\"https:\/\/www.facebook.com\/events\/191876444656545\/?acontext=%7B%22ref%22%3A%222%22%2C%22ref_dashboard_filter%22%3A%22past%22%2C%22action_history%22%3A%22null%22%7D\" target=\"_blank\" rel=\"noopener noreferrer\">atelier sur les services d\u2019analyse de substances<\/a>\u00a0\u00bb. Un \u00e9v\u00e8nement gratuit et ouvert \u00e0 tous, l&#8217;atelier a \u00e9t\u00e9 suivi par des intervenants locaux et internationaux venant d\u2019une vari\u00e9t\u00e9 de disciplines. Certains ayant des connaissances tr\u00e8s approfondies tandis que d\u2019autres venaient pour apprendre davantage sur les principes fondamentaux de l\u2019analyse de substances, les diff\u00e9rents mod\u00e8les d&#8217;\u00e9valuation de la recherche ainsi que de prestation de services actuellement utilis\u00e9s dans le monde. Parmi les conf\u00e9renciers figurent Helena Valente (Universit\u00e9 de Porto, Portugal), Brun Gonzalez (Programa de An\u00e1lisis de Sustancias, Mexico) et Mireia Ventura (Energy Control, Espagne). Les participants ont eu la chance d\u2019avoir acc\u00e8s \u00e0 diff\u00e9rents points de vue des intervenants sur la raison d&#8217;\u00eatre de l\u2019analyse de substances, des m\u00e9thodes efficaces r\u00e9alis\u00e9es sur le terrain et sur la fa\u00e7on de d\u00e9velopper et de soutenir les programmes existants. Les intervenants ont convenu que l\u2019analyse de substances offre beaucoup plus que les r\u00e9sultats des tests. Elle comprend l&#8217;\u00e9ducation et le soutien concernant l&#8217;usage de drogues et rejoint surtout les personnes qui utilisent des drogues, mais n&#8217;interagissent pas avec les services de sant\u00e9 au sujet de leur consommation de drogue. Traditionnellement, la majorit\u00e9 des efforts de r\u00e9duction des m\u00e9faits ont mis l&#8217;accent sur les personnes qui s&#8217;injectent des drogues. M. Gonzalez a qualifi\u00e9 l\u2019analyse de substances comme \u00e9tant essentiel au \u00ab spectre complet de la r\u00e9duction des m\u00e9faits \u00bb, une approche qui fournit des services appropri\u00e9s \u00e0 toutes les personnes qui consomment des substances psychoactives malgr\u00e9 o\u00f9 il se trouve dans leur trajectoire de consommation. Des preuves grandissantes sugg\u00e8rent que la plupart des gens ont l&#8217;intention de changer leurs comportements si leurs r\u00e9sultats apr\u00e8s une analyse de leurs drogues r\u00e9v\u00e8lent certains contenus inattendus ou inconnus qu&#8217;ils envisageaient de prendre (par exemple, ne pas prendre la substance, r\u00e9duire leur dosage, ne pas l\u2019utiliser seul, etc.). Mme Valente a soulign\u00e9 que, bien que les preuves empiriques indiquent que l\u2019analyse de substances est une intervention utile, aller au-del\u00e0 de la recherche sur l&#8217;intention du comportement constituera une \u00e9tape importante dans l&#8217;\u00e9tablissement de donn\u00e9es probantes pour soutenir l&#8217;extension de ces services. La Dre Ventura a soulign\u00e9 la valeur de l\u2019analyse de substances dans le suivi des march\u00e9s de la drogue et permettrait aux d\u00e9cideurs et aux autorit\u00e9s sanitaires de disposer de donn\u00e9es pour notamment r\u00e9pondre aux tendances dangereuses du terrain. De plus, elle note que son organisme, Energy Control, est responsable de la d\u00e9tection d&#8217;environ 65% des nouvelles substances psychoactives. Cette information est ensuite transmise \u00e0 son gouvernement. Les participants ont quitt\u00e9 l&#8217;atelier dynamis\u00e9s, ayant \u00e9largi leurs r\u00e9seaux ainsi que leurs connaissances sur l\u2019analyse de substances.<\/p>\n<p>Un panel en simultan\u00e9 intitul\u00e9 \u00abDrug Checking: From Dance Clubs to the Dark Web\u00bb a continu\u00e9 la discussion sur l\u2019analyse de substances le 15 mai 2017 et a permis aux d\u00e9l\u00e9gu\u00e9s de la conf\u00e9rence d\u2019apprendre encore plus sur les \u00e9valuations de projets novateurs sur l\u2019analyse de substances. Le Dr Mark Lysyshyn a pr\u00e9sent\u00e9 un exemple venant de Vancouver, l&#8217;une des villes du Canada confront\u00e9es \u00e0 une crise importante de surdose d&#8217;opio\u00efdes. Ils ont offert aux personnes fr\u00e9quentant le site d\u2019injection supervis\u00e9 (SIS)\u00a0<em>Insite<\/em>\u00a0des bandes de tests afin qu\u2019ils puissent v\u00e9rifier si leurs substances contenaient du fentanyl. Les recherches du Dr Lysyshyn ont r\u00e9v\u00e9l\u00e9 que le fait de proposer l\u2019analyse de substances pour le fentanyl permettait aux clients d&#8217;utiliser les r\u00e9sultats afin de r\u00e9duire les risques, par exemple, en r\u00e9duisant leur dose qui diminuerait ainsi leur risque de surdose. Ceci sugg\u00e8re que l\u2019analyse de substances pourrait \u00eatre une intervention utile pour pr\u00e9venir les d\u00e9c\u00e8s par surdose dans les sites d\u2019injection supervis\u00e9s. Les pr\u00e9sentateurs ont \u00e9galement particip\u00e9 \u00e0 une conf\u00e9rence de presse plus t\u00f4t dans la journ\u00e9e o\u00f9 les journalistes ont eu la possibilit\u00e9 de poser des questions cibl\u00e9es sur leur recherche sur l\u2019analyse de substances. Julie-Soleil Meeson, membre du Groupe de travail national canadien sur l\u2019analyse de substances, a \u00e9galement fait des remarques lors de la conf\u00e9rence de presse sur les efforts d\u00e9ploy\u00e9s partout au Canada pour mettre en \u0153uvre des projets concrets d&#8217;analyse de substances.<\/p>\n<p>Au-del\u00e0 de la diffusion de l&#8217;information sur la recherche sur l\u2019analyse de substances, HR17 \u00e9tait \u00e9galement un point de diffusion pour les bandes de tests de fentanyl, certains d\u00e9l\u00e9gu\u00e9s de la conf\u00e9rence les ramenant \u00e0 leurs organisations au Canada et \u00e0 l&#8217;\u00e9tranger. Bien qu&#8217;aucun r\u00e9sultat n&#8217;ait \u00e9t\u00e9 recueilli durant la conf\u00e9rence, le bouche-\u00e0-oreille a indiqu\u00e9 qu&#8217;une quantit\u00e9 notable de r\u00e9sultats des bandes de tests \u00e9tait positive pour la pr\u00e9sence de fentanyl.<\/p>\n<p>Nous esp\u00e9rons que l&#8217;accent mis sur l\u2019analyse de substances \u00e0 HR17 a non seulement cr\u00e9\u00e9 un espace pour apprendre et pour partager, mais a \u00e9galement inspir\u00e9 la poursuite des efforts visant \u00e0 cr\u00e9er des strat\u00e9gies de r\u00e9duction des m\u00e9faits qui r\u00e9pondent aux divers besoins des personnes qui utilisent des drogues.<\/p>\n<p><strong>\u00c9crit par: Tara Marie Watson, Caleb Chepesiuk et Nazlee Maghsoudi et traduit par Julie-Soleil Meeson, tous membres du Groupe de travail national canadien sur l\u2019analyse des substances.<\/strong><\/p>\n\n","protected":false},"excerpt":{"rendered":"<p>Avec une attention internationale grandissante sur les impacts et le grand potentiel des services d\u2019analyse de substances, un certain nombre d&#8217;\u00e9v\u00e8nements \u00e0 la conf\u00e9rence de HR17 ont pr\u00e9sent\u00e9 des r\u00e9sultats de recherche ainsi que l\u2019exp\u00e9rience sur le terrain de cette pratique novatrice de r\u00e9duction des m\u00e9faits. Pour la premi\u00e8re fois de son histoire, la\u00a025e Conf\u00e9rence [&hellip;]<\/p>\n","protected":false},"author":38,"featured_media":4154,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_crdt_document":"","footnotes":""},"categories":[32,7],"tags":[],"class_list":["post-4140","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-harm-reduction-fr","category-non-classifiee"],"acf":[],"mb":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>INT\u00c9R\u00caT GRANDISSANT \u00c0 L\u2019INTERNATIONAL POUR L\u2019ANALYSE DE SUBSTANCES : POINTS FORTS DE HR17 - Canadian Drug Policy Coalition<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/mail.canadiandrugpolicy.ca\/fr\/interet-grandissant-a-linternational-pour-lanalyse-de-substances-points-forts-de-hr17\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"INT\u00c9R\u00caT GRANDISSANT \u00c0 L\u2019INTERNATIONAL POUR L\u2019ANALYSE DE SUBSTANCES : POINTS FORTS DE HR17 - Canadian Drug Policy Coalition\" \/>\n<meta property=\"og:description\" content=\"Avec une attention internationale grandissante sur les impacts et le grand potentiel des services d\u2019analyse de substances, un certain nombre d&#8217;\u00e9v\u00e8nements \u00e0 la conf\u00e9rence de HR17 ont pr\u00e9sent\u00e9 des r\u00e9sultats de recherche ainsi que l\u2019exp\u00e9rience sur le terrain de cette pratique novatrice de r\u00e9duction des m\u00e9faits. Pour la premi\u00e8re fois de son histoire, la\u00a025e Conf\u00e9rence [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/mail.canadiandrugpolicy.ca\/fr\/interet-grandissant-a-linternational-pour-lanalyse-de-substances-points-forts-de-hr17\/\" \/>\n<meta property=\"og:site_name\" content=\"Canadian Drug Policy Coalition\" \/>\n<meta property=\"article:published_time\" content=\"2017-06-30T20:36:46+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2019-11-01T21:01:38+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mail.canadiandrugpolicy.ca\/wp-content\/uploads\/2017\/06\/CDPC-Home-Page_Montreal-HRI2017_1600x360px_light-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1600\" \/>\n\t<meta property=\"og:image:height\" content=\"360\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Canadian Drug Policy Coalition\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Canadian Drug Policy Coalition\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/mail.canadiandrugpolicy.ca\\\/fr\\\/interet-grandissant-a-linternational-pour-lanalyse-de-substances-points-forts-de-hr17\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/mail.canadiandrugpolicy.ca\\\/fr\\\/interet-grandissant-a-linternational-pour-lanalyse-de-substances-points-forts-de-hr17\\\/\"},\"author\":{\"name\":\"Canadian Drug Policy Coalition\",\"@id\":\"https:\\\/\\\/mail.canadiandrugpolicy.ca\\\/fr\\\/#\\\/schema\\\/person\\\/c32110f234bdb1f5d978710b6b406a30\"},\"headline\":\"INT\u00c9R\u00caT GRANDISSANT \u00c0 L\u2019INTERNATIONAL POUR L\u2019ANALYSE DE SUBSTANCES : POINTS FORTS DE HR17\",\"datePublished\":\"2017-06-30T20:36:46+00:00\",\"dateModified\":\"2019-11-01T21:01:38+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/mail.canadiandrugpolicy.ca\\\/fr\\\/interet-grandissant-a-linternational-pour-lanalyse-de-substances-points-forts-de-hr17\\\/\"},\"wordCount\":1218,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/mail.canadiandrugpolicy.ca\\\/fr\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/mail.canadiandrugpolicy.ca\\\/fr\\\/interet-grandissant-a-linternational-pour-lanalyse-de-substances-points-forts-de-hr17\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mail.canadiandrugpolicy.ca\\\/wp-content\\\/uploads\\\/2017\\\/06\\\/CDPC-Home-Page_Montreal-HRI2017_1600x360px_light-1.jpg\",\"articleSection\":[\"Harm Reduction\",\"Non classifi\u00e9(e)\"],\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/mail.canadiandrugpolicy.ca\\\/fr\\\/interet-grandissant-a-linternational-pour-lanalyse-de-substances-points-forts-de-hr17\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/mail.canadiandrugpolicy.ca\\\/fr\\\/interet-grandissant-a-linternational-pour-lanalyse-de-substances-points-forts-de-hr17\\\/\",\"url\":\"https:\\\/\\\/mail.canadiandrugpolicy.ca\\\/fr\\\/interet-grandissant-a-linternational-pour-lanalyse-de-substances-points-forts-de-hr17\\\/\",\"name\":\"INT\u00c9R\u00caT GRANDISSANT \u00c0 L\u2019INTERNATIONAL POUR L\u2019ANALYSE DE SUBSTANCES : POINTS FORTS DE HR17 - Canadian Drug Policy Coalition\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/mail.canadiandrugpolicy.ca\\\/fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/mail.canadiandrugpolicy.ca\\\/fr\\\/interet-grandissant-a-linternational-pour-lanalyse-de-substances-points-forts-de-hr17\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/mail.canadiandrugpolicy.ca\\\/fr\\\/interet-grandissant-a-linternational-pour-lanalyse-de-substances-points-forts-de-hr17\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mail.canadiandrugpolicy.ca\\\/wp-content\\\/uploads\\\/2017\\\/06\\\/CDPC-Home-Page_Montreal-HRI2017_1600x360px_light-1.jpg\",\"datePublished\":\"2017-06-30T20:36:46+00:00\",\"dateModified\":\"2019-11-01T21:01:38+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/mail.canadiandrugpolicy.ca\\\/fr\\\/interet-grandissant-a-linternational-pour-lanalyse-de-substances-points-forts-de-hr17\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/mail.canadiandrugpolicy.ca\\\/fr\\\/interet-grandissant-a-linternational-pour-lanalyse-de-substances-points-forts-de-hr17\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/mail.canadiandrugpolicy.ca\\\/fr\\\/interet-grandissant-a-linternational-pour-lanalyse-de-substances-points-forts-de-hr17\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mail.canadiandrugpolicy.ca\\\/wp-content\\\/uploads\\\/2017\\\/06\\\/CDPC-Home-Page_Montreal-HRI2017_1600x360px_light-1.jpg\",\"contentUrl\":\"https:\\\/\\\/mail.canadiandrugpolicy.ca\\\/wp-content\\\/uploads\\\/2017\\\/06\\\/CDPC-Home-Page_Montreal-HRI2017_1600x360px_light-1.jpg\",\"width\":1600,\"height\":360},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/mail.canadiandrugpolicy.ca\\\/fr\\\/interet-grandissant-a-linternational-pour-lanalyse-de-substances-points-forts-de-hr17\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"INT\u00c9R\u00caT GRANDISSANT \u00c0 L\u2019INTERNATIONAL POUR L\u2019ANALYSE DE SUBSTANCES : POINTS FORTS DE HR17\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/mail.canadiandrugpolicy.ca\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/mail.canadiandrugpolicy.ca\\\/fr\\\/\",\"name\":\"Canadian Drug Policy Coalition\",\"description\":\"Change policy. Save lives.\",\"publisher\":{\"@id\":\"https:\\\/\\\/mail.canadiandrugpolicy.ca\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/mail.canadiandrugpolicy.ca\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/mail.canadiandrugpolicy.ca\\\/fr\\\/#organization\",\"name\":\"Canadian Drug Policy Coalition\",\"url\":\"https:\\\/\\\/mail.canadiandrugpolicy.ca\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/mail.canadiandrugpolicy.ca\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/drugpolicy.ca\\\/wp-content\\\/uploads\\\/2019\\\/04\\\/CDPC-logo-white-on-red-150-dpi.jpg\",\"contentUrl\":\"https:\\\/\\\/drugpolicy.ca\\\/wp-content\\\/uploads\\\/2019\\\/04\\\/CDPC-logo-white-on-red-150-dpi.jpg\",\"width\":332,\"height\":333,\"caption\":\"Canadian Drug Policy Coalition\"},\"image\":{\"@id\":\"https:\\\/\\\/mail.canadiandrugpolicy.ca\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/mail.canadiandrugpolicy.ca\\\/fr\\\/#\\\/schema\\\/person\\\/c32110f234bdb1f5d978710b6b406a30\",\"name\":\"Canadian Drug Policy Coalition\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/9f79e2b1a0ccc3ac68e2c3b14806186aa5e053de86cb3e0ee34e1971e8c4a3f7?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/9f79e2b1a0ccc3ac68e2c3b14806186aa5e053de86cb3e0ee34e1971e8c4a3f7?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/9f79e2b1a0ccc3ac68e2c3b14806186aa5e053de86cb3e0ee34e1971e8c4a3f7?s=96&d=mm&r=g\",\"caption\":\"Canadian Drug Policy Coalition\"},\"description\":\"Advocating for public health- and human rights-based drug policy grounded in evidence, compassion, and social justice\",\"url\":\"https:\\\/\\\/mail.canadiandrugpolicy.ca\\\/fr\\\/author\\\/canadian-drug-policy-coalition\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"INT\u00c9R\u00caT GRANDISSANT \u00c0 L\u2019INTERNATIONAL POUR L\u2019ANALYSE DE SUBSTANCES : POINTS FORTS DE HR17 - Canadian Drug Policy Coalition","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/mail.canadiandrugpolicy.ca\/fr\/interet-grandissant-a-linternational-pour-lanalyse-de-substances-points-forts-de-hr17\/","og_locale":"fr_FR","og_type":"article","og_title":"INT\u00c9R\u00caT GRANDISSANT \u00c0 L\u2019INTERNATIONAL POUR L\u2019ANALYSE DE SUBSTANCES : POINTS FORTS DE HR17 - Canadian Drug Policy Coalition","og_description":"Avec une attention internationale grandissante sur les impacts et le grand potentiel des services d\u2019analyse de substances, un certain nombre d&#8217;\u00e9v\u00e8nements \u00e0 la conf\u00e9rence de HR17 ont pr\u00e9sent\u00e9 des r\u00e9sultats de recherche ainsi que l\u2019exp\u00e9rience sur le terrain de cette pratique novatrice de r\u00e9duction des m\u00e9faits. Pour la premi\u00e8re fois de son histoire, la\u00a025e Conf\u00e9rence [&hellip;]","og_url":"https:\/\/mail.canadiandrugpolicy.ca\/fr\/interet-grandissant-a-linternational-pour-lanalyse-de-substances-points-forts-de-hr17\/","og_site_name":"Canadian Drug Policy Coalition","article_published_time":"2017-06-30T20:36:46+00:00","article_modified_time":"2019-11-01T21:01:38+00:00","og_image":[{"width":1600,"height":360,"url":"https:\/\/mail.canadiandrugpolicy.ca\/wp-content\/uploads\/2017\/06\/CDPC-Home-Page_Montreal-HRI2017_1600x360px_light-1.jpg","type":"image\/jpeg"}],"author":"Canadian Drug Policy Coalition","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Canadian Drug Policy Coalition","Dur\u00e9e de lecture estim\u00e9e":"6 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/mail.canadiandrugpolicy.ca\/fr\/interet-grandissant-a-linternational-pour-lanalyse-de-substances-points-forts-de-hr17\/#article","isPartOf":{"@id":"https:\/\/mail.canadiandrugpolicy.ca\/fr\/interet-grandissant-a-linternational-pour-lanalyse-de-substances-points-forts-de-hr17\/"},"author":{"name":"Canadian Drug Policy Coalition","@id":"https:\/\/mail.canadiandrugpolicy.ca\/fr\/#\/schema\/person\/c32110f234bdb1f5d978710b6b406a30"},"headline":"INT\u00c9R\u00caT GRANDISSANT \u00c0 L\u2019INTERNATIONAL POUR L\u2019ANALYSE DE SUBSTANCES : POINTS FORTS DE HR17","datePublished":"2017-06-30T20:36:46+00:00","dateModified":"2019-11-01T21:01:38+00:00","mainEntityOfPage":{"@id":"https:\/\/mail.canadiandrugpolicy.ca\/fr\/interet-grandissant-a-linternational-pour-lanalyse-de-substances-points-forts-de-hr17\/"},"wordCount":1218,"commentCount":0,"publisher":{"@id":"https:\/\/mail.canadiandrugpolicy.ca\/fr\/#organization"},"image":{"@id":"https:\/\/mail.canadiandrugpolicy.ca\/fr\/interet-grandissant-a-linternational-pour-lanalyse-de-substances-points-forts-de-hr17\/#primaryimage"},"thumbnailUrl":"https:\/\/mail.canadiandrugpolicy.ca\/wp-content\/uploads\/2017\/06\/CDPC-Home-Page_Montreal-HRI2017_1600x360px_light-1.jpg","articleSection":["Harm Reduction","Non classifi\u00e9(e)"],"inLanguage":"fr-FR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/mail.canadiandrugpolicy.ca\/fr\/interet-grandissant-a-linternational-pour-lanalyse-de-substances-points-forts-de-hr17\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/mail.canadiandrugpolicy.ca\/fr\/interet-grandissant-a-linternational-pour-lanalyse-de-substances-points-forts-de-hr17\/","url":"https:\/\/mail.canadiandrugpolicy.ca\/fr\/interet-grandissant-a-linternational-pour-lanalyse-de-substances-points-forts-de-hr17\/","name":"INT\u00c9R\u00caT GRANDISSANT \u00c0 L\u2019INTERNATIONAL POUR L\u2019ANALYSE DE SUBSTANCES : POINTS FORTS DE HR17 - Canadian Drug Policy Coalition","isPartOf":{"@id":"https:\/\/mail.canadiandrugpolicy.ca\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/mail.canadiandrugpolicy.ca\/fr\/interet-grandissant-a-linternational-pour-lanalyse-de-substances-points-forts-de-hr17\/#primaryimage"},"image":{"@id":"https:\/\/mail.canadiandrugpolicy.ca\/fr\/interet-grandissant-a-linternational-pour-lanalyse-de-substances-points-forts-de-hr17\/#primaryimage"},"thumbnailUrl":"https:\/\/mail.canadiandrugpolicy.ca\/wp-content\/uploads\/2017\/06\/CDPC-Home-Page_Montreal-HRI2017_1600x360px_light-1.jpg","datePublished":"2017-06-30T20:36:46+00:00","dateModified":"2019-11-01T21:01:38+00:00","breadcrumb":{"@id":"https:\/\/mail.canadiandrugpolicy.ca\/fr\/interet-grandissant-a-linternational-pour-lanalyse-de-substances-points-forts-de-hr17\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/mail.canadiandrugpolicy.ca\/fr\/interet-grandissant-a-linternational-pour-lanalyse-de-substances-points-forts-de-hr17\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/mail.canadiandrugpolicy.ca\/fr\/interet-grandissant-a-linternational-pour-lanalyse-de-substances-points-forts-de-hr17\/#primaryimage","url":"https:\/\/mail.canadiandrugpolicy.ca\/wp-content\/uploads\/2017\/06\/CDPC-Home-Page_Montreal-HRI2017_1600x360px_light-1.jpg","contentUrl":"https:\/\/mail.canadiandrugpolicy.ca\/wp-content\/uploads\/2017\/06\/CDPC-Home-Page_Montreal-HRI2017_1600x360px_light-1.jpg","width":1600,"height":360},{"@type":"BreadcrumbList","@id":"https:\/\/mail.canadiandrugpolicy.ca\/fr\/interet-grandissant-a-linternational-pour-lanalyse-de-substances-points-forts-de-hr17\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.drugpolicy.ca\/fr\/"},{"@type":"ListItem","position":2,"name":"INT\u00c9R\u00caT GRANDISSANT \u00c0 L\u2019INTERNATIONAL POUR L\u2019ANALYSE DE SUBSTANCES : POINTS FORTS DE HR17"}]},{"@type":"WebSite","@id":"https:\/\/mail.canadiandrugpolicy.ca\/fr\/#website","url":"https:\/\/mail.canadiandrugpolicy.ca\/fr\/","name":"Canadian Drug Policy Coalition","description":"Change policy. Save lives.","publisher":{"@id":"https:\/\/mail.canadiandrugpolicy.ca\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/mail.canadiandrugpolicy.ca\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/mail.canadiandrugpolicy.ca\/fr\/#organization","name":"Canadian Drug Policy Coalition","url":"https:\/\/mail.canadiandrugpolicy.ca\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/mail.canadiandrugpolicy.ca\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/drugpolicy.ca\/wp-content\/uploads\/2019\/04\/CDPC-logo-white-on-red-150-dpi.jpg","contentUrl":"https:\/\/drugpolicy.ca\/wp-content\/uploads\/2019\/04\/CDPC-logo-white-on-red-150-dpi.jpg","width":332,"height":333,"caption":"Canadian Drug Policy Coalition"},"image":{"@id":"https:\/\/mail.canadiandrugpolicy.ca\/fr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/mail.canadiandrugpolicy.ca\/fr\/#\/schema\/person\/c32110f234bdb1f5d978710b6b406a30","name":"Canadian Drug Policy Coalition","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/9f79e2b1a0ccc3ac68e2c3b14806186aa5e053de86cb3e0ee34e1971e8c4a3f7?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/9f79e2b1a0ccc3ac68e2c3b14806186aa5e053de86cb3e0ee34e1971e8c4a3f7?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9f79e2b1a0ccc3ac68e2c3b14806186aa5e053de86cb3e0ee34e1971e8c4a3f7?s=96&d=mm&r=g","caption":"Canadian Drug Policy Coalition"},"description":"Advocating for public health- and human rights-based drug policy grounded in evidence, compassion, and social justice","url":"https:\/\/mail.canadiandrugpolicy.ca\/fr\/author\/canadian-drug-policy-coalition\/"}]}},"mfb_rest_fields":["title","yoast_head","yoast_head_json"],"_links":{"self":[{"href":"https:\/\/mail.canadiandrugpolicy.ca\/fr\/wp-json\/wp\/v2\/posts\/4140","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mail.canadiandrugpolicy.ca\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mail.canadiandrugpolicy.ca\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mail.canadiandrugpolicy.ca\/fr\/wp-json\/wp\/v2\/users\/38"}],"replies":[{"embeddable":true,"href":"https:\/\/mail.canadiandrugpolicy.ca\/fr\/wp-json\/wp\/v2\/comments?post=4140"}],"version-history":[{"count":1,"href":"https:\/\/mail.canadiandrugpolicy.ca\/fr\/wp-json\/wp\/v2\/posts\/4140\/revisions"}],"predecessor-version":[{"id":7499,"href":"https:\/\/mail.canadiandrugpolicy.ca\/fr\/wp-json\/wp\/v2\/posts\/4140\/revisions\/7499"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/mail.canadiandrugpolicy.ca\/fr\/wp-json\/wp\/v2\/media\/4154"}],"wp:attachment":[{"href":"https:\/\/mail.canadiandrugpolicy.ca\/fr\/wp-json\/wp\/v2\/media?parent=4140"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mail.canadiandrugpolicy.ca\/fr\/wp-json\/wp\/v2\/categories?post=4140"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mail.canadiandrugpolicy.ca\/fr\/wp-json\/wp\/v2\/tags?post=4140"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}